[HTML][HTML] Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities

ED Mock, B Gagestein, M van der Stelt - Progress in Lipid Research, 2023 - Elsevier
Abstract N-acylethanolamines (NAEs), including N-palmitoylethanolamine (PEA), N-
oleoylethanolamine (OEA), N-arachidonoylethanolamine (AEA, anandamide), N …

Bioactive lipids, inflammation and chronic diseases

A Leuti, D Fazio, M Fava, A Piccoli, S Oddi… - Advanced Drug Delivery …, 2020 - Elsevier
Endogenous bioactive lipids are part of a complex network that modulates a plethora of
cellular and molecular processes involved in health and disease, of which inflammation …

From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology

A Ligresti, L De Petrocellis… - Physiological …, 2016 - journals.physiology.org
Apart from having been used and misused for at least four millennia for, among others,
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …

Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication

JB Funcke, PE Scherer - Journal of lipid research, 2019 - ASBMB
The breakthrough discoveries of leptin and adiponectin more than two decades ago led to a
widespread recognition of adipose tissue as an endocrine organ. Many more adipose tissue …

Pathophysiology of human visceral obesity: an update

A Tchernof, JP Després - Physiological reviews, 2013 - journals.physiology.org
Excess intra-abdominal adipose tissue accumulation, often termed visceral obesity, is part of
a phenotype including dysfunctional subcutaneous adipose tissue expansion and ectopic …

CB1 and CB2 receptor pharmacology

AC Howlett, ME Abood - Advances in Pharmacology, 2017 - Elsevier
The CB 1 and CB 2 cannabinoid receptors (CB 1 R, CB 2 R) are members of the G protein-
coupled receptor (GPCR) family that were identified over 20 years ago. CB 1 Rs and CB 2 …

Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity

PD Cani, M Osto, L Geurts, A Everard - Gut microbes, 2012 - Taylor & Francis
Obesity is associated with metabolic alterations related to glucose homeostasis and
cardiovascular risk factors. These metabolic alterations are associated with low-grade …

Endocannabinoids—at the crossroads between the gut microbiota and host metabolism

PD Cani, H Plovier, M Van Hul, L Geurts… - Nature Reviews …, 2016 - nature.com
Various metabolic disorders are associated with changes in inflammatory tone. Among the
latest advances in the metabolism field, the discovery that gut microorganisms have a major …

The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders

C Silvestri, V Di Marzo - Cell metabolism, 2013 - cell.com
Endocannabinoids and cannabinoid CB1 receptors are known to play a generalized role in
energy homeostasis. However, clinical trials with the first generation of CB1 blockers, now …

The endocannabinoid system links gut microbiota to adipogenesis

GG Muccioli, D Naslain, F Bäckhed… - Molecular systems …, 2010 - embopress.org
Obesity is characterised by altered gut microbiota, low‐grade inflammation and increased
endocannabinoid (eCB) system tone; however, a clear connection between gut microbiota …